Agios Pharmaceuticals AGIO Treasury Stock, Value
Treasury Stock, Value at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's treasury stock, value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's treasury stock, value?
- Agios Pharmaceuticals (AGIO) reported treasury stock, value of $802.49M in Q1 2026.
- How has Agios Pharmaceuticals's treasury stock, value changed year-over-year?
- Agios Pharmaceuticals's treasury stock, value decreased by 0.0% year-over-year, from $802.49M to $802.49M.
- What does treasury stock, value mean?
- This represents the cost of common shares that the company has repurchased from the open market and holds in its treasury. Treasury stock reduces total shareholders' equity and is often used for employee stock compensation plans or to return capital to shareholders. It is recorded as a contra-equity account.